Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kaltura Inc (KLTR) vs Sanofi SA (SNY) Price & Performance

Kaltura IncTrade

Price performance (Past 24H)

Key statistics

Kaltura Inc vs Sanofi SA — how do they compare? Kaltura Inc trades at $1.63 (market cap $249.42M), while Sanofi SA trades at $43.51 (market cap $104.30B). The key difference: Sanofi SA is far larger — about 418.2× Kaltura Inc's market cap, and Sanofi SA pays a 5.55% dividend while Kaltura Inc pays none. Which is the better fit depends on your goals.

KLTRSNY
Market Cap
$249.42M$104.30B
Sector
TechnologyHealth
52-Week High
$1.89$52.34
52-Week Low
$1.08$41.33
Enterprise Value
$261.64M$124.19B
Dividend Yield
5.55%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Kaltura Inc

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)

Read more on KLTR

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY